Table of Contents: 2025 JANUARY–FEBRUARY No. 462

RxNorm January 2025 Monthly Release

RxNorm January 2025 Monthly Release. NLM Tech Bull. 2025 Jan-Feb;(462):b2.

2025 January 07 [posted]

The RxNorm January 2025 monthly release became available on Monday, January 6, 2025.

New Qualitative Distinction: Shortage Import Unapproved

We have added a new Qualitative Distinction (Shortage Import Unapproved) in cases where the label indicates that the U.S. Food and Drug Administration (FDA) does not consider the product to be directly substitutable with the product manufactured in the United States. For example:

U.S. Products:

RXCUI	TTY	STR
1795610	SCD	250 ML glucose 50 MG/ML Injection
1795610	PSN	dextrose 5 % in 250 ML Injection
1795610	SY	dextrose 5 % per 250 ML Injection
1795612	SCD	1000 ML glucose 50 MG/ML Injection
1795612	PSN	dextrose 5 % in 1000 ML Injection
1795612	SY	dextrose 5 % per 1000 ML Injection

Imported Products:

RXCUI	TTY	STR
2698220	SCD	Shortage Import Unapproved 250 ML glucose 50 MG/ML Injection
2698220	PSN	dextrose 5 % in 250 ML Injection, Shortage Import Unapproved
2698220	SY	dextrose 5 % per 250 ML Injection, Shortage Import Unapproved
2698221	SCD	Shortage Import Unapproved 1000 ML glucose 50 MG/ML Injection
2698221	PSN	dextrose 5 % in 1000 ML Injection, Shortage Import Unapproved
2698221	SY	dextrose 5 % per 1000 ML Injection, Shortage Import Unapproved

See the Health Care Professional Letter in DailyMed for more information.

Learn more about Qualitative Distinctions in RxNorm.